1|This document should not be distributed without Cegedim authorization – Copyright 2012

RECENT TRENDS IN AGGREGATE SPEND AND DISCLOSURE COMPLIANCE – US / EMEA / APAC

Results from Industry Surveys

|This document should not be distributed without Cegedim authorization – Copyright 2012

2

Global | Transparency Reporting Importance

%percentage points increase in Importance between 2012 & 2011

2012 Cegedim U.S. Aggregate Spend Survey

3|This document should not be distributed without Cegedim authorization – Copyright 2012

UNITED STATES

This document should not be distributed without Cegedim authorization – Copyright 20124|

Concerns with Complying with ‘Sunshine’

Slight Decreases vs. 2011

This document should not be distributed without Cegedim authorization – Copyright 20125|

The Sunshine Act is Prompting Companies To Outsource Reporting Compliance

67% Plan To Move To An Automated SolutionMoving To An Internal Automated Solution Is Down From 28% In 2011 To 13%

This document should not be distributed without Cegedim authorization – Copyright 20126|

Collection Method from Third Parties

Continual Decline In Respondents Using Solely Spreadsheets To Obtain Spend Data From Vendors

This document should not be distributed without Cegedim authorization – Copyright 20127|

Pre-Submission Review

63% of respondents are planning on a “pre-submission review” by covered recipients

This document should not be distributed without Cegedim authorization – Copyright 20128|

Foreign Spend on US HCPs

When US Physicians Travel Abroad On Behalf Of Foreign Affiliate(s), Most Respondents Report That They Do Capture Those Payments/Expenses For Reporting Under US Federal Law

9|This document should not be distributed without Cegedim authorization – Copyright 2012

EUROPE & COMPARISON TO US

This document should not be distributed without Cegedim authorization – Copyright 201110|

Expected Timeline for Transparency and Disclosure in Europe to Reach US Levels

64%1 to 3 Years

16%3 to 5 Years

7%Less than 1 Year

This document should not be distributed without Cegedim authorization – Copyright 201211|

41%Collecting required compliance data –

Country Head Office

39%Analyzing Needs –

Country Head Office

16%Waiting for More European Laws

Current State of Readiness for Transparency Requirements

This document should not be distributed without Cegedim authorization – Copyright 201212|

EU vs. US | Satisfying Reporting & Disclosure Requirements

This document should not be distributed without Cegedim authorization – Copyright 201213|

EU vs. US | What are the Issues Affecting Promotional Spend Compliance?

This document should not be distributed without Cegedim authorization – Copyright 201214|

EU vs. US | Investment Direction

15|This document should not be distributed without Cegedim authorization – Copyright 2012

APAC

This document should not be distributed without Cegedim authorization – Copyright 201216|

APAC Compliance Survey Results Purpose of Business Compliance in the Pharmaceutical Industry

(Total of Strongly Agree and Agree Percentages)

This document should not be distributed without Cegedim authorization – Copyright 201217|

APAC Compliance Survey Results In Which Areas Does your Company Collect Spend Data?

This document should not be distributed without Cegedim authorization – Copyright 201218|

APAC Compliance Survey Results Is Your Company Planning to Increase Investments on Compliance Transparency Tools

and Resources?

This document should not be distributed without Cegedim authorization – Copyright 201219|

APAC Compliance Survey Results Future Trends - Total of Strongly Agree and Agree Percentages

|This document should not be distributed without Cegedim authorization – Copyright 2012

20

Global Trends Summary

US is ahead of Europe & APAC

Pharma is ahead of Med Device & Biotech companies

Legislators throughout Europe forging ahead with transparency laws

Operational compliance practices are underway in EU

Investigation & analysis phase underway in APAC

LATAM ???

3–5 yrs

|This document should not be distributed without Cegedim authorization – Copyright 2012

21

Compliance as a Competitive Advantage

Compliance as a business advantage that fosters innovation and contribute to commercial sustainability

Commercial Model

Product Marketability

Company Reputability

+Brand

Awareness

+Appropriate interactions

Inappropriate interactions

Reputation